China Nuclear Medicine Market Size & Outlook, 2023-2030
China nuclear medicine market, 2018-2030 (US$M)
Related Markets
China nuclear medicine market highlights
- The China nuclear medicine market generated a revenue of USD 352.7 million in 2023 and is expected to reach USD 735.9 million by 2030.
- The China market is expected to grow at a CAGR of 11.1% from 2024 to 2030.
- In terms of segment, diagnostics was the largest revenue generating product in 2023.
- Therapeutics is the most lucrative product segment registering the fastest growth during the forecast period.
Nuclear medicine market data book summary
| Market revenue in 2023 | USD 352.7 million |
| Market revenue in 2030 | USD 735.9 million |
| Growth rate | 11.1% (CAGR from 2023 to 2030) |
| Largest segment | Diagnostics |
| Fastest growing segment | Therapeutics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Jubilant Pharmova, Nordion, Bracco, Iren SpA, Abliva AB, Lantheus Holdings Inc, Eckert & Ziegler Bebig SA, Mallinckrodt PLC Ordinary Shares - New, Cardinal Health Inc |
Other key industry trends
- In terms of revenue, China accounted for 3.4% of the global nuclear medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan nuclear medicine market is projected to lead the regional market in terms of revenue in 2030.
- Singapore is the fastest growing regional market in Asia Pacific and is projected to reach USD 187.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nuclear Medicine Market Scope
Nuclear Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China nuclear medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nuclear medicine market will help companies and investors design strategic landscapes.
Diagnostics was the largest segment with a revenue share of 76.61% in 2023. Horizon Databook has segmented the China nuclear medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
The demand for 99Mo/99mTc is increasing in China. There are currently two ongoing projects in the country that are focused on producing Mo-99 to meet the rising demand. Projects include the China Advanced Research Reactor (CARR), which started operations in 2010 & the testing of Mo-99 is expected to start by 2020 and Medical Isotope Production Reactor (MIPR), which is operated by the Nuclear Power Institute of China (NPIC).
More than 800 hospitals in China have nuclear medicine facilities. For instance, China Isotope & Radiation Corporation (CIRC), a subsidiary of China National Nuclear Corporation (CNNC), has exported seven different kinds of products, including design & installation for Cobalt-60 radiation processing facility, radioactive sources, 99Mo-99mTc generator, and 99mTc kits, to more than 50 countries.
Local companies entering into licensing agreements with foreign organizations for the production & development of radioisotopes is expected to boost market growth in China. For instance, in November 2019, ITM Isotopen Technologien München AG (ITM) & Chengdu Gaotong Isotope Co., Ltd. entered into a licensing agreement to produce and distribute ITM’s Germanium-68/Gallium-68 Generators and n.c.a Lu-177 (EndolucinBeta) in China.
Reasons to subscribe to China nuclear medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China nuclear medicine market databook
-
Our clientele includes a mix of nuclear medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China nuclear medicine market , including forecasts for subscribers. This country databook contains high-level insights into China nuclear medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China nuclear medicine market size, by product, 2018-2030 (US$M)
China Nuclear Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
